Tag: SOF-XX
ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
Featured Article
APS Industrial brings Siemens’ next-gen PLC to Aussie manufacturers
As the manufacturing industry advances towards greater automation and digitalisation, companies are seeking smarter and more efficient control solutions to enhance their operations.
